309 related articles for article (PubMed ID: 27216623)
1. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
[TBL] [Abstract][Full Text] [Related]
3. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
4.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
5. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
Hu Y; Zeng F
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
[TBL] [Abstract][Full Text] [Related]
6. GSH-Activated NIR Fluorescent Prodrug for Podophyllotoxin Delivery.
Liu Y; Zhu S; Gu K; Guo Z; Huang X; Wang M; Amin HM; Zhu W; Shi P
ACS Appl Mater Interfaces; 2017 Sep; 9(35):29496-29504. PubMed ID: 28758393
[TBL] [Abstract][Full Text] [Related]
7. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
8. Redox Dual-Responsive and O
Chen H; Li F; Yao Y; Wang Z; Zhang Z; Tan N
Theranostics; 2019; 9(1):90-103. PubMed ID: 30662556
[TBL] [Abstract][Full Text] [Related]
9. ATP-Responsive and Near-Infrared-Emissive Nanocarriers for Anticancer Drug Delivery and Real-Time Imaging.
Qian C; Chen Y; Zhu S; Yu J; Zhang L; Feng P; Tang X; Hu Q; Sun W; Lu Y; Xiao X; Shen QD; Gu Z
Theranostics; 2016; 6(7):1053-64. PubMed ID: 27217838
[TBL] [Abstract][Full Text] [Related]
10. β-Galactosidase-activated theranostic for hepatic carcinoma therapy and imaging.
Maiti M; Kikuchi K; Athul KK; Kaur A; Bhuniya S
Chem Commun (Camb); 2022 May; 58(44):6413-6416. PubMed ID: 35543438
[TBL] [Abstract][Full Text] [Related]
11. Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing.
Li Q; Cao J; Wang Q; Zhang J; Zhu S; Guo Z; Zhu WH
J Mater Chem B; 2019 Mar; 7(9):1503-1509. PubMed ID: 32255021
[TBL] [Abstract][Full Text] [Related]
12. A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion.
Sun T; Zhang G; Wang Q; Chen Q; Chen X; Lu Y; Liu L; Zhang Y; He X; Ruan C; Zhang Y; Guo Q; Jiang C
Biomaterials; 2018 Nov; 183():268-279. PubMed ID: 30179777
[TBL] [Abstract][Full Text] [Related]
13. A Simple Glutathione-Responsive Turn-On Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy.
Li Y; Wu Y; Chen J; Wan J; Xiao C; Guan J; Song X; Li S; Zhang M; Cui H; Li T; Yang X; Li Z; Yang X
Nano Lett; 2019 Aug; 19(8):5806-5817. PubMed ID: 31331172
[TBL] [Abstract][Full Text] [Related]
14. Alginate-based cancer-associated, stimuli-driven and turn-on theranostic prodrug nanogel for cancer detection and treatment.
Pei M; Jia X; Zhao X; Li J; Liu P
Carbohydr Polym; 2018 Mar; 183():131-139. PubMed ID: 29352868
[TBL] [Abstract][Full Text] [Related]
15. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics.
Zheng X; Zhang F; Zhao Y; Zhang J; Dawulieti J; Pan Y; Cui L; Sun M; Shao D; Li M; He K; Zhang M; Li J; Chen L
Theranostics; 2018; 8(14):3808-3823. PubMed ID: 30083261
[TBL] [Abstract][Full Text] [Related]
17. Photo-triggered fluorescent theranostic prodrugs as DNA alkylating agents for mechlorethamine release and spatiotemporal monitoring.
Cao Y; Pan R; Xuan W; Wei Y; Liu K; Zhou J; Wang W
Org Biomol Chem; 2015 Jun; 13(24):6742-8. PubMed ID: 25997534
[TBL] [Abstract][Full Text] [Related]
18. Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy.
Qian J; Xu Z; Meng C; Liu Y; Wu H; Wang Y; Yang J; Zheng H; Ran F; Liu GQ; Ling Y
J Med Chem; 2022 Aug; 65(15):10393-10407. PubMed ID: 35877176
[TBL] [Abstract][Full Text] [Related]
19. pH/Redox-Triggered Photothermal Treatment for Cancer Therapy Based on a Dual-Responsive Cationic Polymer Dot.
Mazrad ZAI; Phuong PTM; Choi CA; In I; Lee KD; Park SY
ChemMedChem; 2018 Nov; 13(22):2437-2447. PubMed ID: 30288948
[TBL] [Abstract][Full Text] [Related]
20. A highly GSH-sensitive SN-38 prodrug with an "OFF-to-ON" fluorescence switch as a bifunctional anticancer agent.
Whang CH; Yoo E; Hur SK; Kim KS; Kim D; Jo S
Chem Commun (Camb); 2018 Aug; 54(65):9031-9034. PubMed ID: 30047958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
